Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Higher serum levels of vitamin D are associated with lower blood glucose levels

Texto completo
Autor(es):
Valladares, Tania [1] ; Cardoso, Maria Regina [2] ; Aldrighi, Jose Mendes [2]
Número total de Autores: 3
Afiliação do(s) autor(es):
[1] Univ Sao Paulo, Sch Publ Hlth, Dept Mother & Child Hlth, Sao Paulo - Brazil
[2] Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Sao Paulo - Brazil
Número total de Afiliações: 2
Tipo de documento: Artigo Científico
Fonte: MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY; v. 26, n. 7, p. 781-784, JUL 2019.
Citações Web of Science: 1
Resumo

Objective: Vitamin D plays an important role in bone metabolism. There is now evidence that a higher serum level of 25-hydroxyvitamin D (25{[}OH] D) is associated with a lower risk of developing type 2 diabetes mellitus, because it provides better glycemic control, possibly by promoting greater insulin sensitivity, and also by improving pancreatic beta cell function. The objective of the present study was to evaluate the possible association between 25(OH) D sufficiency and glycemia. Methods: This was a cross-sectional study involving 680 women, 35 to 74 years of age, selected through systematic sampling. From each participant, fasting blood samples were collected for the determination of 25(OH) D and glucose levels. Results: The mean fasting blood glucose level was 105 mg/dL (range 26-401 mg/dL). Fasting serum levels of 25(OH) D were <30 ng/mL in 65.4% of the participants and <20 ng/mL in 25.6%. A serum 25(OH) D level < 30 ng/mL was positively associated with a blood glucose level >= 100 mg/dL (odds ratio {[}OR] 1.29, 95% confidence interval {[}CI] 1.05-1.57), as was a serum 25(OH) D level < 20 ng/mL (OR 1.25, 95% CI 1.04-1.50). Conclusions: Lower serum 25(OH) D concentrations appear to be associated with a high blood glucose levels. (AU)

Processo FAPESP: 13/00302-7 - Projeto de saúde de Pindamonhangaba: PROSAPIN-II
Beneficiário:José Mendes Aldrighi
Modalidade de apoio: Auxílio à Pesquisa - Regular